|
ATLANTA, Oct. 16, 2014 /PRNewswire/ -- Amidst the Ebola outbreak and subsequent research efforts, Atlanta-based Intellimedix is bringing a new approach to the table. Classical methods of drug development involve performing many experiments only to identify new molecules with a few desired... |
